What smart money is saying about OptimizeRx
1 fund in our archive has pitched OptimizeRx — most recently White Brook Capital Ethical Strategies in September 2026.
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Get an email when a fund buys, sells or pitches it
Position history
Every position in OptimizeRx on record in the archive was reported in Q3 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 0 | 1 |
Fund activity · 1 position
- September 2026
“OptimizeRx (OPRX) is recovering after a round trip in its share price.”
OptimizeRx
Fund coverage · 1 thesis
- White Brook Capital Ethical StrategiesSeptember 2026
OptimizeRx is considered attractively priced on reduced 2026 sales, with improved ad monetization and a likely recovery in 2027.
Read the full thesis
Read every full thesis on OptimizeRx
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→